Clinical Trial Update: PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial [Phase 4]

View source ↗

Summary

A randomized Phase 4 trial evaluated macitentan for portopulmonary hypertension, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Portopulmonary Hypertension

Drugs mentioned

• Macitentan (macitentan)

Snippet

Sponsor: Actelion | Conditions: Portopulmonary Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2018-11-23